EADV24: Semaglutide Shows Promising Outcomes for Obese Patients with Hidradenitis Suppurativa
A study presented Wednesday, 25 September 2024, at the EADV Congress 2024 in Amsterdam highlights the significant potential of semaglutide in treating hidradenitis suppurativa (HS) in obese patients.